GGrantIndex
← Leaderboards

Alexander Staruschenko

James A. Haley Va Medical Center

$10,255,251
Attributed
$11,682,477
Total exposure
9
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY201225
$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,682,477 · 8
VA$0 · 1

By mechanism

R01$6,264,615 · 4
R35$3,615,233 · 1
P01$1,351,504 · 1
R21$411,125 · 1
R13$40,000 · 1
I01$0 · 1

Top collaborators

Others in their field

Top investigators on “Kidney

Research focus

KidneyPlayRattusRegulationKidney DiseasesSignal PathwayHomeostasisPathway InteractionsLeadDahl Hypertensive RatsPublishingMediatingChronicIn VivoFunctional DisorderSignal TransductionSalt Sensitive HypertensionPhysiologicalDesignReportingSalt SensitiveLaboratoriesHypertensionInjury

Grant awards (36)

Sexual dimorphisms and role of the cGAS-STING pathway in diabetic nephropathy$512,560
R01 · FY2025 · DK · contact PI
Renal diabetic complications mediated by the PAR1 signaling in podocytes$326,322
R01 · FY2025 · DK · contact PI
Transport and metabolism in the kidney$0
I01 · FY2025 · VA · contact PI
Sexual dimorphisms and role of the cGAS-STING pathway in diabetic nephropathy$492,057
R01 · FY2024 · DK · contact PI
Renal diabetic complications mediated by the PAR1 signaling in podocytes$313,685
R01 · FY2024 · DK · contact PI
Transport and metabolism in the kidney$0
I01 · FY2024 · VA · contact PI
Renal ion channels in the control of blood pressure$570,153
R35 · FY2023 · HL · contact PI
Sexual dimorphisms and role of the cGAS-STING pathway in diabetic nephropathy$524,794
R01 · FY2023 · DK · contact PI
Renal diabetic complications mediated by the PAR1 signaling in podocytes$327,151
R01 · FY2023 · DK · contact PI
Renal ion channels in the control of blood pressure$513,138
R35 · FY2022 · HL · contact PI
Renal diabetic complications mediated by the PAR1 signaling in podocytes$341,495
R01 · FY2022 · DK · contact PI
Smart patch of podocytes$224,250
R21 · FY2022 · DK · contact PI
Hypertension Scientific Sessions 2022$40,000
R13 · FY2022 · HL · contact PI
Purinergic control of calcium flux in podocytes$0
I01 · FY2022 · VA · contact PI
Renal ion channels in the control of blood pressure$587,314
R35 · FY2021 · HL · contact PI
Physiology Core$312,376
P01 · FY2021 · HL · contact PI
Smart patch of podocytes$186,875
R21 · FY2021 · DK · contact PI
Purinergic control of calcium flux in podocytes$0
I01 · FY2021 · VA · contact PI
Renal ion channels in the control of blood pressure$587,314
R35 · FY2020 · HL · contact PI
Physiology Core$344,960
P01 · FY2020 · HL · contact PI
Purinergic control of calcium flux in podocytes$0
I01 · FY2020 · VA · contact PI
Renal ion channels in the control of blood pressure$587,314
R35 · FY2019 · HL · contact PI
Physiology Core$347,084
P01 · FY2019 · HL · contact PI
Purinergic control of calcium flux in podocytes$0
I01 · FY2019 · VA · contact PI
Renal ion channels in the control of blood pressure$385,000
R35 · FY2018 · HL · contact PI
Role of NOX4 In Kidney Function In Salt-Sensitive Hypertension$383,785
R01 · FY2018 · HL
Physiology Core$347,084
P01 · FY2018 · HL · contact PI
Renal ion channels in the control of blood pressure$385,000
R35 · FY2017 · HL · contact PI
Role of NOX4 In Kidney Function In Salt-Sensitive Hypertension$383,823
R01 · FY2017 · HL
Role of NOX4 In Kidney Function In Salt-Sensitive Hypertension$383,299
R01 · FY2016 · HL
Mechanisms and relevance of ENaC regulation by EGF and Rac1$382,500
R01 · FY2016 · HL · contact PI
Role of NOX4 In Kidney Function In Salt-Sensitive Hypertension$394,892
R01 · FY2015 · HL
Mechanisms and relevance of ENaC regulation by EGF and Rac1$376,762
R01 · FY2015 · HL · contact PI
Mechanisms and relevance of ENaC regulation by EGF and Rac1$374,850
R01 · FY2014 · HL · contact PI
Mechanisms and relevance of ENaC regulation by EGF and Rac1$364,140
R01 · FY2013 · HL · contact PI
Mechanisms and relevance of ENaC regulation by EGF and Rac1$382,500
R01 · FY2012 · HL · contact PI